Enochian Biosciences Inc.

NASDAQ: ENOB · Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM

Enochian Biosciences Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-81.64M -38,556.9B -116.08M -23.4M
Interest Income
n/a n/a 122.04K 13.18K
Pretax Income
-80.65M -39,684.1B -113.43M -26.85M
Net Income
-80.65M -39,684.1B -113.43M -26.72M
Selling & General & Admin
24.56M 15,318.2B 14.33M 7.74M
Research & Development
2.71M 4,165.2B 8.37M 15.54M
Other Expenses
54.37M 19,073.5B 123.59K 123.53K
Operating Expenses
81.64M 38,556.9B 22.83M 23.4M
Interest Expense
-1.01M -580.34B 372.84K 379.61K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 38,556.9B 22.83M 23.4M
Income Tax Expense
n/a n/a 34.00 -125K
Shares Outstanding (Basic)
96.25M 56.27M 52.53M 47.17M
Shares Outstanding (Diluted)
96.25M 56.27M 52.53M 47.17M
EPS (Basic)
-0.84 -705.3K -2.16 -0.57
EPS (Diluted)
-0.84 -705.3K -2.16 -0.57
EBITDA
-81.52M -38,443.4B -113,682.7B -27.11M
EBIT
-81.64M -40,264.4B -116,079.2B -26.47M
Depreciation & Amortization
121.86K 113.5B 123.59B 404.59K